Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Trevi Therapeutics, Inc. (TRVI)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 59,920,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Trevi Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (nalbuphine ER) to treat neurologically mediated conditions. Co. is developing Haduvio for the treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis. These conditions share a common pathophysiology that is mediated through opioid receptors in the central and peripheral nervous systems. Haduvio is an oral extended-release formulation of nalbuphine. Nalbuphine is a mixed k-opioid receptor agonist and m-opioid receptor antagonist.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 4,037 1,013,351
Total Sell Value $0 $0 $9,602 $2,860,266
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 6 15
End Date 2024-01-18 2023-10-17 2023-04-18 2022-04-18

   
Records found: 128
  Page 1 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Delfini Lisa Chief Financial Officer   •       –      –    2023-10-11 4 AS $2.02 $1,586 D/D (785) 35,901     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-10-11 4 OE $0.51 $1,171 D/D 2,292 36,686     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-09-11 4 AS $2.20 $1,564 D/D (711) 34,394     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-09-11 4 OE $0.51 $1,171 D/D 2,291 35,105     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-08-11 4 AS $2.36 $1,610 D/D (682) 32,814     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-08-11 4 OE $0.51 $1,171 D/D 2,292 33,496     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-07-11 4 AS $2.34 $1,608 D/D (687) 31,204     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-07-11 4 OE $0.51 $1,171 D/D 2,292 31,891     -
   Simon Farrell Chief Commercial Officer   •       –      –    2023-06-20 4 OE $0.51 $3,194 D/D 6,250 45,650     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-06-12 4 AS $2.64 $1,610 D/D (610) 29,599     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-06-12 4 OE $0.51 $1,171 D/D 2,291 30,209     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-05-11 4 AS $2.89 $1,624 D/D (562) 27,918     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-05-11 4 OE $0.51 $1,171 D/D 2,291 28,480     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-04-11 4 AS $1.84 $1,545 D/D (840) 26,189     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-04-11 4 OE $0.51 $1,171 D/D 2,292 27,029     -
   Simon Farrell Chief Commercial Officer   •       –      –    2023-03-07 4 OE $0.51 $9,581 D/D 18,750 39,400     -
   Simon Farrell Chief Commercial OfficerOffice   •       –      –    2023-02-16 3 IO $0.00 $0 D/D 0 20,650     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-02-13 4 AS $2.45 $20,761 D/D (8,474) 23,338     -
   Delfini Lisa Chief Financial Officer   •       –      –    2023-02-13 4 OE $0.51 $14,053 D/D 27,500 31,812     -
   Winkelried Jon Former 10% Owner   –       –      –    2022-07-05 4 S $3.11 $197,827 I/I (63,569) 3,824,883     -
   Winkelried Jon Former 10% Owner   –       –      –    2022-07-01 4 S $2.86 $1,246,185 I/I (436,431) 3,888,452     -
   Winkelried Jon 10% Owner   –       –       •   2022-06-30 4 S $2.77 $1,191,898 I/I (429,838) 4,324,883     -
   Winkelried Jon 10% Owner   –       –       •   2022-06-29 4 S $2.74 $126,303 I/I (46,128) 4,754,721     -
   Winkelried Jon 10% Owner   –       –       •   2022-05-02 4 S $2.70 $1,620 I/I (600) 4,800,849     -
   Winkelried Jon 10% Owner   –       –       •   2022-04-29 4 S $2.75 $44,385 I/I (16,163) 4,801,449     -

  128 Records found
  1  2  3  4  5  6   
  Page 1 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed